Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Credly is a leading digital credentialing platform that enables organizations to issue, manage, and verify digital badges and certificates. While primarily an educational and HR technology company, Credly is a critical infrastructure provider in the healthcare and life sciences sectors, where it is used to verify professional certifications, continuing medical education (CME), and specialized technical skills. The platform is utilized by major industry bodies, including the American Heart Association and the Biotechnology Innovation Organization (BIO), to provide a verified record of workforce competencies. In January 2022, Credly was acquired by Pearson for approximately $200 million, becoming a core part of Pearson's workforce skills division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Credly.